| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7513074 | International Journal of Drug Policy | 2015 | 6 Pages |
Abstract
Current evidence indicates that DBS testing availability may increase the uptake of testing for HCV in high-risk populations. There is currently no evidence regarding the efficacy of PoC testing in these populations.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Josh T. Coats, John F. Dillon,